We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Nuclear Medicine Approach Shows Promise for Treating Cancerous Tumors

News   Jun 26, 2018 | Original story from Society of Nuclear Medicine and Molecular Imaging (SNMMI)

 
Nuclear Medicine Approach Shows Promise for Treating Cancerous Tumors

225Ac-proteus-DOTA hapten can be targeted in vivo to GPA33-expressing human colorectal cancer xenografts using anti-GPA33-DOTA-PRIT, with minimal radioactive uptake in critical radiosensitive tissues such as blood and kidney. In addition, indium-111 can be used in place of 225Ac as a convenient imaging surrogate (biomarker) of 225Ac in vivo biodistribution and dosimetry. Credit: SM Cheal et al., Memorial Sloan Kettering Cancer Center, New York, NY.

 
 
Advertisement
 

RELATED ARTICLES

New Anti-Alzheimer's Compound Reverses Memory Decline in Mice

News

A drug candidate previously shown to slow aging in brain cells has successfully reversed memory loss in a mouse model of inherited Alzheimer’s disease.

READ MORE

Two Is Better Than One for Novel COVID-19 Mouse Model

News

Researchers have developed a new mouse model to study SARS-CoV-2 infection and disease and to accelerate testing of novel treatments and vaccines against the novel coronavirus.

READ MORE

"Floppy" Proteins Used To Create Artificial Organelles Within Human Cells

News

Biomedical engineers have developed a method for controlling the phase separation of an emerging class of proteins to create artificial membrane-less organelles within human cells.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE